213 related articles for article (PubMed ID: 6201023)
1. [Fibronectin and other immunologic parameters in chronic polyarthritis].
Siegmeth W; Minar E; Graninger W; Pirich K; Zazgornik J
Z Rheumatol; 1984; 43(1):27-9. PubMed ID: 6201023
[TBL] [Abstract][Full Text] [Related]
2. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.
Mallya RK; Vergani D; Tee DE; Bevis L; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
Clin Exp Immunol; 1982 Jun; 48(3):747-53. PubMed ID: 6981476
[TBL] [Abstract][Full Text] [Related]
3. [Complement fragment C 3d in the plasma of patients with chronic polyarthritis].
Stannat S; Peter HH; Raspe HH; Deicher H
Z Rheumatol; 1986; 45(2):47-51. PubMed ID: 3487899
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin in rheumatoid and non-rheumatoid arthritic synovial fluids and in synovial fluid cryoproteins.
Lu-Steffes M; Iammartino AJ; Schmid FR; Castor CW; Davis L; Entwistle R; Anderson B
Ann Clin Lab Sci; 1982; 12(3):178-85. PubMed ID: 7092168
[TBL] [Abstract][Full Text] [Related]
5. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
Stojan B
Z Rheumatol; 1976; 35(7-8):272-7. PubMed ID: 961078
[TBL] [Abstract][Full Text] [Related]
6. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
Molenaar ET; Voskuyl AE; Familian A; van Mierlo GJ; Dijkmans BA; Hack CE
Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
[TBL] [Abstract][Full Text] [Related]
7. [A comparative study of serum complement (C3 and C4) in inflammatory joint diseases].
Dacheva V; Dimov DM; Nedialkova V; Koleva P
Vutr Boles; 1990; 29(5):68-74. PubMed ID: 1706901
[TBL] [Abstract][Full Text] [Related]
8. Some humoral immunological aspects of the rheumatoid arthritis correlated with the ultrastructural changes of the rheumatoid synovial fluid.
Ciobanu A; Ciobanu IR; Ioniţă A; Stoicescu M; Stroescu I; Caralicea M; Curuţ O
Rom J Morphol Embryol; 1992; 38(3-4):143-54. PubMed ID: 1285262
[TBL] [Abstract][Full Text] [Related]
9. Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis.
Vaziri ND; Gonzales E; Barton CH; Chen HT; Nguyen Q; Arquilla M
J Lab Clin Med; 1991 Feb; 117(2):152-6. PubMed ID: 1993857
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of C reactive protein, alpha1 antitrypsin, and complement (C3, C4, C1 esterase inhibitor) before and during the Vuelta a Espańa.
Semple SJ; Smith LL; McKune AJ; Hoyos J; Mokgethwa B; San Juan AF; Lucia A; Wadee AA
Br J Sports Med; 2006 Feb; 40(2):124-7. PubMed ID: 16431998
[TBL] [Abstract][Full Text] [Related]
11. [Blood and synovial levels of 2 complement fractions].
Ambanelli U; Troise W; Nervetti A
Reumatismo; 1972; 24(3):233-40. PubMed ID: 4549699
[No Abstract] [Full Text] [Related]
12. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
Wolfe F
J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
[TBL] [Abstract][Full Text] [Related]
13. Immunologic evaluation of rheumatoid arthritis and therapy with levamisole.
Verhaegen H; de Cree J; de Cock W; Schuermans Y; Engels M; Sonck W
Biomedicine; 1977 Jul; 26(4):283-91. PubMed ID: 922113
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
[TBL] [Abstract][Full Text] [Related]
15. alpha1-acid glycoprotein and alpha1-antitrypsin as early markers of treatment response in patients receiving the intensive phase of tuberculosis therapy.
Almeida ML; Barbieri MA; Gurgel RQ; Abdurrahman ST; Baba UA; Hart CA; Shenkin A; Silva AM; de Souza L; Cuevas LE
Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):575-80. PubMed ID: 19211120
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
17. [The role of recently identified proteins in rheumatoid inflammation].
Ambanelli U; Ferraccioli GF; Maini M; Rocca E
Boll Soc Ital Biol Sper; 1978 Apr; 54(7):593-9. PubMed ID: 81065
[No Abstract] [Full Text] [Related]
18. [Behavior of the complement components C3 and C4, C-reactive protein and blood sedimentation rate for activity control in arthritis patients during thermo-hydrotherapy].
Günther R; Spath P; Egg D; Geier W; Nachbauer E
Z Rheumatol; 1978; 37(1-2):33-9. PubMed ID: 629093
[TBL] [Abstract][Full Text] [Related]
19. [Examination of acute phase proteins concentrations in children with allergic rhinitis].
Steiner I; Sobieska M; Pucher B; Grzegorowski M; Samborski W
Ann Acad Med Stetin; 2006; 52(2):33-7; discussion 37. PubMed ID: 17633124
[TBL] [Abstract][Full Text] [Related]
20. Concentration of fibronectin and granulocyte elastase in plasma of patients with systemic connective-tissue diseases.
Schneider M; Lohmann J; Krummenerl T; Gerlach U
Int J Tissue React; 1987; 9(4):355-9. PubMed ID: 3497902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
